Search

everythinglearnresearchcommunity

for

Search:↓

A woman with lymphoma had a rare skin rash on her scalp and forehead, which was hard to diagnose but responded well to treatment.

A 68-year-old woman with lupus and blood disorders improved after increased steroids and immunoglobulin treatment.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

A patient with a rare form of lupus improved after treatment for skin ulcers and hair loss on the face and scalp.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

Follicular dystrophy in immunocompromised patients may be linked to medication or viral factors and can improve with treatment changes.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

Immunological treatment improved both neuropathy and alopecia.

SADBE treatment led to complete hair regrowth in mice with alopecia areata by altering immune cell movement.

Anti-phospholipid antibodies in SLE can cause thrombosis and bone necrosis.

The dense fine speckled pattern in ANA tests is common in autoimmune diseases, challenging previous beliefs that it was unrelated.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Dupilumab treatment reduces Th2-related markers and helps hair growth in alopecia areata, showing Th2's role in the condition.

B cells can both help and hinder the body's defense against melanoma.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

ILC1-like cells may contribute to hair loss in alopecia areata.

Dupilumab can both improve and worsen alopecia areata, with higher IgE levels linked to better outcomes.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

Dupilumab may cause hair loss in some patients with severe atopic dermatitis.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

A(1-7) treatment reduces symptoms of lupus in mice.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

Hair follicles produce IL-7, which is essential for certain skin lymphoma cells to survive.